Data / Form D filings / X-Vax Technology, Inc.
X-Vax Technology, Inc.: Form D filings
X-Vax Technology, Inc., a biotechnology company in Jupiter, FL, filed 6 Form D notices with the SEC between 2016 and 2019. The latest, on July 18, 2019, reports $56.5 million sold of a $58 million offering to 306 investors.
Find out what X-Vax Technology, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 HERITAGE DRIVE, SUITE 138, Jupiter, FL, 33458
- Phone
- (212) 956-1111
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1682900
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 18, 2019 | Amendment | $58,000,000 | $56,463,455 | $1,536,545 | 306 | Sep 28, 2018 | sec.gov |
| May 31, 2019 | Amendment | $55,000,000 | $46,682,455 | $8,317,545 | 269 | Sep 28, 2018 | sec.gov |
| Apr 17, 2019 | Amendment | $55,000,000 | $42,187,450 | $12,812,550 | 242 | Sep 28, 2018 | sec.gov |
| Apr 15, 2019 | Amendment | $55,000,000 | $39,267,450 | $15,732,550 | 230 | Sep 28, 2018 | sec.gov |
| Oct 3, 2018 | New notice | $30,000,000 | $6,550,000 | $23,450,000 | 9 | Sep 28, 2018 | sec.gov |
| Sep 12, 2016 | New notice | $1,000,000 | $100,000 | $900,000 | 1 | Sep 6, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ulf Wiinberg | Executive Officer | |
| Andreas Eggert | Executive Officer | |
| Jacob Uittenbogaard | Executive Officer | |
| Clare Kahn | Executive Officer | |
| Richard Kenney | Executive Officer | |
| Ian T. Clark | Director | |
| Matthew R. Stober | Director | |
| Brian D. Finn | Director | |
| William A. Haseltine | Director | |
| Roger A. Jeffs | Director | |
| Roger J. Pomerantz | Director | |
| Robert R. Ruffolo | Director | |
| Isaac T. Blech | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
- RHEOS MEDICAL CORP. $387,773 · Oct 7, 2026
- DIGITAL ETHER COMPUTING, LLC $625,000 · Sep 23, 2026
- Jupiter Biomedical Research, Inc. $30,000 · Sep 21, 2026
- Kaida BioPharma Inc. $1.6 million · Sep 1, 2026
- StrataBio Inc. $25,000 · Aug 31, 2026
- LUREX BIO, INC $150,000 · Aug 31, 2026
- EXUMA Biotech Corp. $70 million · Aug 20, 2026
- CRESCEL LLC $1.1 million · Aug 19, 2026
- EnduraFAST Inc. $50,000 · Aug 17, 2026
Every Form D from the week of Jul 15, 2019 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what X-Vax Technology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.